Additional Paid In Capital [Member] Statement Equity Components [Axis] Common Stock [Member] Accumulated Deficit [Member] Warrant Share [Member] Financial Instrument [Axis] Warrants Financial Instrument [Axis] Merck Serono Agreement Counterparty Name [Axis] Pharmaceutical Research Associates, Inc Remaining Balance From Prior Payment To Pharmaceutical Research Associates, Inc. Document And Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Subscription receivable Other current assets Total current assets Property & equipment, net of accumulated depreciation of $2,516,189 and $2,443,600, respectively Other long-term assets Total assets Liabilities and Stockholders' Equity Current liabilities: Accounts payable Accrued expenses Deferred revenue Notes payable - insurance Total current liabilities Long term liabilities: Deferred revenue, net of current portion Total liabilities Commitments and contingencies Stockholders' equity: Preferred stock, no par value, 10,000,000 shares authorized, none issued and outstanding Common stock, $0.01 par value, 150,000,000 shares authorized, 6,982,909 and 6,982,909 shares issued and outstanding Additional paid in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Property & equipment, accumulated depreciation Preferred stock, no par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue: Option Revenue Research and development General and administrative Loss on disposition of assets Depreciation and amortization Operating loss Interest income, net Other income and expense, net Net loss Basic and diluted loss per share Weighted average shares outstanding - Basic and diluted Statement [Table] Statement [Line Items] Equity Components [Axis] Beginning Balance, Shares Beginning Balance, Amount Cancellation of fractional shares, Shares Cancellation of fractional shares, Amount Shares issued under the at-the-market program, shares Shares issued under the at-the-market program, amount Costs associated with rights offering Common stock sold for cash, Shares Common stock sold for cash, Amount Exercise of warrants, Shares Exercise of warrants, Amount Option expense Net loss Ending Balance, Shares Ending Balance, Amount Statement of Cash Flows [Abstract] Cash flows from operating activities Adjustments to reconcile net loss to net cash provided by (used in) operating activities Restricted stock expense Shares issued for services Depreciation Loss on disposition of equipment Option expense Changes in: Other current assets Accounts payable Accrued expenses Deferred revenue Other long-term assets Net cash used in operating activities Cash flows from investing activities Purchase of property & equipment Net cash used in investing activities Cash flows from financing activities Common stock and warrants sold for cash, net of offering costs Cash generated from exercise of warrants Cash paid for fractional shares Note payable - insurance Payment of deferred offering costs Net cash provided by financing activities Net change in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash paid for: Interest Income taxes NON-CASH TRANSACTIONS Unpaid offering costs Unpaid additions to property and equipment Subscription receivable Conversion of notes payable to common stock Issuance of common stock for accrued interest Discount on convertible notes relating to: Warrants Beneficial conversion feature Unpaid additions to property and equipment Shares issued as deferred offering costs Accounting Policies [Abstract] Basis of Presentation Significant Accounting Polices Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Other Current Assets Equity [Abstract] Equity Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock-Based Compensation Revenue Recognition Cash and Cash Equivalents Reclassifications Other Current Assets Stock Option Activity Warrant Activity Significant Accounting Polices Details Cash in savings account Interest income Custom reagents Deferred offering costs Prepaid expenses Total Other Current Assets Advance payments to vendors and consultants Options Number of Shares, Outstanding at beginning of period Options, Granted Options, Exercised Options, Forfeited and canceled Number of Shares, Outstanding at end of period Number of Shares, Exercisable at end of period Weighted Average Exercise Price, Options Weighted average exercise price, Outstanding at beginning of period Weighted average exercise price options, Granted Weighted average exercise price options, Exercised Weighted average exercise price options, Forfeited and canceled Weighted average exercise price, Outstanding at end of period Weighted average exercise price, Exercisable at end of period Weighted Average Remaining Contract Term, Options Weighted Average Remaining Contract Term, Outstanding at beginning of period Weighted Average Remaining Contract Term, Outstanding at end of period Weighted Average Remaining Contract Term, Exercisable Intrinsic Value, Options Outstanding Aggregate Intrinsic Value, beginning of period Outstanding Aggregate Intrinsic Value, end of period Exercisable Aggregate Intrinsic Value Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Class of Warrant or Right [Axis] Warrants Number of Shares, Outstanding at beginning of period Warrants, Granted Warrants, Exercised Warrants, Forfeited and canceled Number of Shares, Outstanding at end of period Number of Shares, Exercisable at end of period Weighted Average Exercise Price, Warrants Weighted average exercise price, Outstanding at beginning of period Weighted average exercise price warrants, Granted Weighted average exercise price warrants, Exercised Weighted average exercise price warrants, Forfeited and canceled Weighted average exercise price, Outstanding at end of period Weighted average exercise price, Exercisable at end of period Weighted Average Remaining Contract Term, Warrants Weighted Average Remaining Contract Term, Outstanding at beginning of period Weighted Average Remaining Contract Term, Outstanding at end of period Weighted Average Remaining Contract Term, Exercisable Intrinsic Value, Warrants Outstanding Aggregate Intrinsic Value, Beginning of period Aggregate Intrinsic Value Granted Aggregate Intrinsic Value Exercised Aggregate Intrinsic Value Forfeited Outstanding Aggregate Intrinsic Value, End of period Exercisable Aggregate Intrinsic Value Stock-based Compensation Details Narrative Unamortized stock-based compensation expense Option expense Cash Paid During Period For [Abstract] Discount On Convertible Notes Related To [Abstract] Discount On Convertible Notes Related To Beneficial Conversion Feature Discount On Convertible Notes Related To Warrants Document And Entity Information [Abstract] Other Assets, Current [Line Items] Other Assets, Current [Table] Warrant Share [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract] Share Based Compensation Arrangements By Share Based Payment Award Options Grant In Period Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Exercise Price Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Operating Income (Loss) Shares, Outstanding Stock Issued During Period, Value, Issued for Services Stock or Unit Option Plan Expense Increase (Decrease) in Other Current Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Deferred Revenue Increase (Decrease) in Other Noncurrent Assets Net Cash Provided by (Used in) Operating Activities, Continuing Operations Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities, Continuing Operations CashPaidForFractionalShares Repayments of Notes Payable Payments of Stock Issuance Costs Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) SubscriptionReceivable DiscountOnConvertibleNotesRelatedToWarrants Capital Expenditures Incurred but Not yet Paid Schedule of Other Current Assets [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value StockholdersEquityWarrantsOrRightsRollforward StockholdersEquityWarrantsOrRightsOutstandingNumberOfUnderlyingShares StockholdersEquityWarrantsOrRightsExercisableOutstandingNumberOfUnderlyingShares StockholdersEquityWarrantsOrRightsOutstandingWeightedAverageExercisePriceOfUnderlyingShares StockholdersEquityWarrantsOrRightsOutstandingWeightedAverageExercisePriceOfExercisableUnderlyingShares StockholdersEquityWarrantsOrRightsOutstandingWeightedAverageRemainingContractualTermInYears StockholdersEquityWarrantsOrRightsOutstandingWeightedAverageRemainingContractualTermInYearsEnd StockholdersEquityWarrantsOrRightsExercisableOutstandingWeightedAverageRemainingContractualTermInYears StockholdersEquityWarrantsOrRightsOutstandingIntrinsicValue StockholdersEquityWarrantsOrRightsExercisableIntrinsicValue Allocated Share-based Compensation Expense OtherAssetsCurrentLineItems OtherAssetsCurrentTable